Clinical Trials Browser

Not yet recruiting × Pancreatic Neoplasms × nimotuzumab × Clear all

NCT06409429 2024-05-10

Nimotuzumab Combined With GX as Postoperative Adjuvant Therapy in Pancreatic Cancer

Phase 2/3 Not yet recruiting

Gastrointestinal

Pancreatic Neoplasms